|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2292232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10182449.8 |
| Date of filing the European patent application | 2002-07-05 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 303474 P | 2001-07-06 | US |
| (72) |
Edmondson, Scott, D., US
Fisher, Michael, H., US
Kim, Dooseop, US
Maccoss, Malcolm, US
Parmee, Emma, R., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | BETA-AMINO TETRAHYDROIMIDAZO(1,2-A)PYRAZINES AND TETRAHYDROTRIAZOLO(4,3-A)PYRAZINES FOR USE IN THE TREATMENT OF DIABETES TYPE II |
| BETA-AMINO TETRAHYDROIMIDAZO(1,2-A)PYRAZINES AND TETRAHYDROTRIAZOLO(4,3-A)PYRAZINES FOR USE IN THE TREATMENT OF DIABETES TYPE II |